Ubs Asset Management Americas Inc Immunity Bio, Inc. Transaction History
Ubs Asset Management Americas Inc
- $381 Billion
- Q3 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 1,544,802 shares of IBRX stock, worth $4.06 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,544,802
Previous 1,577,827
2.09%
Holding current value
$4.06 Million
Previous $9.97 Million
42.52%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding IBRX
# of Institutions
204Shares Held
70MCall Options Held
1.68MPut Options Held
1.31M-
Vanguard Group Inc Valley Forge, PA16.9MShares$44.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$30 Million0.0% of portfolio
-
State Street Corp Boston, MA8.65MShares$22.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.85MShares$10.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.25MShares$5.91 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.05B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...